This company listing is no longer active
INDVR Brands Past Earnings Performance
Past criteria checks 0/6
Key information
36.1%
Earnings growth rate
69.0%
EPS growth rate
Pharmaceuticals Industry Growth | 23.1% |
Revenue growth rate | 18.6% |
Return on equity | -76.2% |
Net Margin | -530.7% |
Last Earnings Update | 31 Oct 2021 |
Recent past performance updates
Recent updates
Revenue & Expenses Breakdown
How INDVR Brands makes and spends money. Based on latest reported earnings, on an LTM basis.
Earnings and Revenue History
Date | Revenue | Earnings | G+A Expenses | R&D Expenses |
---|---|---|---|---|
31 Oct 21 | 1 | -6 | 4 | 0 |
31 Jul 21 | 1 | -6 | 4 | 0 |
30 Apr 21 | 1 | -6 | 4 | 0 |
31 Jan 21 | 1 | -6 | 4 | 0 |
31 Oct 20 | 1 | -10 | 5 | 0 |
31 Jul 20 | 0 | -10 | 5 | 0 |
30 Apr 20 | 1 | -9 | 4 | 0 |
31 Jan 20 | 1 | -20 | 6 | 0 |
31 Dec 18 | 2 | -2 | 2 | 0 |
30 Sep 18 | 2 | -1 | 2 | 0 |
31 Dec 17 | 1 | 0 | 0 | 0 |
Quality Earnings: IDVR is currently unprofitable.
Growing Profit Margin: IDVR is currently unprofitable.
Free Cash Flow vs Earnings Analysis
Past Earnings Growth Analysis
Earnings Trend: Insufficient data to determine if IDVR's year-on-year earnings growth rate was positive over the past 5 years.
Accelerating Growth: Unable to compare IDVR's earnings growth over the past year to its 5-year average as it is currently unprofitable
Earnings vs Industry: IDVR is unprofitable, making it difficult to compare its past year earnings growth to the Pharmaceuticals industry (14.5%).
Return on Equity
High ROE: IDVR has a negative Return on Equity (-76.25%), as it is currently unprofitable.